article thumbnail

NIH licenses COVID-19 technologies to WHO-backed program

Healthcare Dive

The agreement, which covers three experimental vaccines as well as several key patents, makes products sold in 49 low-income countries royalty-free.

COVID-19 355
article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Moderna also licensed their mRNA technology from Cellscript LLC – University of Pennsylvania’s successor-in-interest to the 966 patent.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strategic Maneuvers in Response to COVID-19 Denialist Laws and Policies

Bill of Health

Over the course of the COVID-19 pandemic, now entering its fourth year in 2023, legislators, executives, and judges at every level of government have sought measures to derail efficacious public health interventions. And most relate solely to COVID-19 interventions, which sunset permanently as states withdraw their emergencies.

COVID-19 176
article thumbnail

Health workers' licenses at risk if they spread COVID-19 vaccine misinformation

Fierce Healthcare

Health workers' licenses at risk if they spread COVID-19 vaccine misinformation. agliadkovskaya. Thu, 09/09/2021 - 13:11.

article thumbnail

State Nursing Boards Continue to Delay Licenses Across the U.S. As COVID-19 Pandemic Continues

The Health Law Firm

Board Certified by The Florida Bar in Health Law Staffing shortages at hospitals across the US are worsening helped along by state boards and other licensing authorities taking months to process nursing licenses, a recent NPR survey claims. Indest III, J.D., Now, it's resulted in a considerable backlog in nurses waiting for jobs.

article thumbnail

Nomi Health battling allegations it copied app licensed to support its COVID-19 testing business

Fierce Healthcare

A contract and copyright dispute over the development of a COVID-19 testing app has left Nomi Health with an order to pay more than $7 million in damages, which could potentially balloon into a hig | Nomi Health has already admitted to breaching its licensing contract with software developer OSGHD and was ordered to pay over $7 million in damages, (..)

article thumbnail

Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’

Bill of Health

Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. However, some suggest that patents are impeding access to research.

COVID-19 167